Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8757573 | Contemporary Clinical Trials | 2018 | 23 Pages |
Abstract
CADMUS will provide level one evidence on the performance of mpUSS derived targeted biopsies in the identification of clinically significant prostate cancer in comparison to mpMRI targeted biopsies. Recruitment is underway and expected to complete in 2018.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Alistair Grey, Rebecca Scott, Susan Charman, Jan van der Meulen, Peter Frinking, Peter Acher, Sidath Liyanage, Sanjeev Madaan, Gabriel Constantinescu, Bina Shah, Chris Brew Graves, Alex Freeman, Charles Jameson, Navin Ramachandran, Mark Emberton,